LONDON MARKET MIDDAY: Stocks slide; UK roadmap announcement ahead Read More
LONDON MARKET OPEN: Burberry sinks as CEO Gobbetti heads home Read More
PRESS: GSK hires Goldman and Citi for spinoff of Consumer Healthcare Read More
BROKER RATINGS: Deutsche raises GSK; HSBC cuts BP to Hold Read More
TOP NEWS: AstraZeneca prostate cancer drug Lynparza backed in China Read More
LONDON MARKET CLOSE: Stocks edge lower as PMI does little to impress Read More
TOP NEWS: GSK unveils plans for payout cut and consumer spin-off Read More
LONDON MARKET MIDDAY: Europe down but oil and mining stocks boost FTSE Read More
GlaxoSmithKline's ViiV signs deal for "ultra long-acting" HIV drugs Read More
GSK-Vir Covid treatment sees positive results in mild, moderate cases Read More
IP Group investee Apollo Therapeutics completes USD145 million raise Read More
BROKER RATINGS: Bank of America double upgrades Morrisons to Buy Read More
TOP NEWS: GlaxoSmithKline in USD2.1 billion cancer treatment tie-up Read More
BROKER RATINGS: Deutsche Bank downgrades Ashtead to Hold from Buy Read More
EXECUTIVE CHANGES: Gresham House and Gresham House Strategic make up Read More
GSK encourages ADS holders to reject TRC Capital "mini-tender" offer Read More
TOP NEWS: GSK and Sanofi launch phase three study for Covid vaccine Read More
US regulator authorises GSK and Vir's sotrovimab for Covid treatment Read More
IN BRIEF: Crossword Cybersecurity bolsters board with two appointments Read More
IN BRIEF: GlaxoSmithKline's sotrovimab gets EMA positive opinion Read More
